DermTech, Inc. (DMTKQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
Inactive · Last trade price on Aug 12, 2025
DermTech Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 15.66 | 15.3 | 14.52 | 11.84 | 5.89 | 3.36 |
Revenue Growth | 9.71% | 5.36% | 22.64% | 101.16% | 74.94% | 37.76% |
Gross Profit Gross Profit Growth | 1.33 | 0.28 | 0.65 | 1.27 | -0.1 | 0.06 |
Operating Income Operating Income Growth | -86.5 | -98.04 | -118.17 | -77.4 | -35.29 | -17.61 |
Net Income Net Income Growth | -89.63 | -100.89 | -116.68 | -78.34 | -36.48 | -20.13 |
Earnings Per Share EPS Growth | -2.67 | -3.09 | -3.88 | -2.71 | -2.15 | -2.87 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Mar '19 Mar 31, 2019 |
DermTech Melanoma Test DermTech Melanoma Test Growth | 14.38 | 13.79 | 11.02 | 4.24 | 1.4 |
Smart Stickers Smart Stickers Growth | 0.59 | 0.15 | 0.35 | 0.21 | 0.48 |
Ribonucleic Acid Extractions Ribonucleic Acid Extractions Growth | 0.23 | 0.26 | 0.3 | 1.17 | 0.63 |
Project Management Project Management Growth | 0.09 | 0.32 | 0.17 | 0.26 | 0.34 |
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 38.98 | 55.86 | 126.17 | 225.33 | 63.78 | 15.37 |
Total Debt Total Debt Growth | 53.67 | 54.39 | 55.83 | 7.86 | 0.34 | - |
Net Cash (Debt) Net Cash Growth | -14.69 | 1.47 | 70.34 | 217.47 | 63.44 | 15.37 |
Net Cash Growth | - | -97.91% | -67.66% | 242.79% | 312.66% | - |
Net Cash Per Share Net Cash Per Share Growth | -0.44 | 0.05 | 2.34 | 7.53 | 3.74 | 2.19 |
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -72.07 | -76.98 | -95.26 | -62.11 | -28.68 | -17.79 |
Capital Expenditures CapEx Growth | -0.15 | -0.9 | -3.31 | -2.72 | -1.83 | -0.21 |
Free Cash Flow Free Cash Flow Growth | -72.22 | -77.88 | -98.57 | -64.83 | -30.52 | -18 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | 8.51% | 1.80% | 4.46% | 10.76% | -1.63% | 1.78% |
Operating Margin | -552.23% | -640.94% | -813.92% | -653.81% | -599.64% | -523.33% |
Pretax Margin | -572.19% | -659.57% | -803.71% | -661.72% | -619.83% | -598.39% |
Profit Margin | -572.19% | -659.57% | -803.71% | -661.73% | -619.83% | -598.39% |
FCF Margin | -461.02% | -509.16% | -678.92% | -547.61% | -518.57% | -535.11% |
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PS Ratio | 0 | 3.92 | 3.68 | 39.66 | 108.02 | 44.10 |